does semaglutide burn fat or suppress appetite How Wegovy (Semaglutide) Work? GLP-1 Genetics: How Genes Affect

Studies of GLP-1 RAs in type 2 diabetes GLP-1 RAs have shown effects on glycaemic control and weight loss in clinical trials

Less common but more serious risks may include pancreatitis, gallbladder issues, kidney problems, or allergic reactions

SGLT2 inhibitors, such as empagliflozin and canagliflozin, have similar A1C-lowering properties (0.5%-0.8%) and out-of-pocket costs (except for alogliptin, which is available generically), but have the added advantages of CV risk reduction, BP-lowering, and weight loss

None of these are binary or all-or-nothing

The development represents an expansion of therapeutic availability rather than a structural change in care delivery